Discounted Cash Flow (DCF) Analysis Levered
OrthoPediatrics Corp. (KIDS)
$30.09
-1.42 (-4.51%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 57.56 | 72.55 | 71.08 | 98.05 | 122.29 | 148.79 | 181.03 | 220.27 | 268 | 326.08 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -15.58 | -17.77 | -18.53 | -13.06 | -21.77 | -32.36 | -39.38 | -47.91 | -58.29 | -70.93 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -5.46 | -12.09 | -11.30 | -16.01 | -10.03 | -19.81 | -24.11 | -29.33 | -35.69 | -43.42 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -21.05 | -29.85 | -29.83 | -29.07 | -31.80 | -52.18 | -63.48 | -77.24 | -93.98 | -114.35 |
Weighted Average Cost Of Capital
| Share price | $ 30.09 |
|---|---|
| Beta | 0.855 |
| Diluted Shares Outstanding | 20.95 |
| Cost of Debt | |
| Tax Rate | 134.10 |
| After-tax Cost of Debt | -91.14% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 8.771 |
| Total Debt | 0.91 |
| Total Equity | 630.32 |
| Total Capital | 631.22 |
| Debt Weighting | 0.14 |
| Equity Weighting | 99.86 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 57.56 | 72.55 | 71.08 | 98.05 | 122.29 | 148.79 | 181.03 | 220.27 | 268 | 326.08 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.58 | -17.77 | -18.53 | -13.06 | -21.77 | -32.36 | -39.38 | -47.91 | -58.29 | -70.93 |
| Capital Expenditure | -5.46 | -12.09 | -11.30 | -16.01 | -10.03 | -19.81 | -24.11 | -29.33 | -35.69 | -43.42 |
| Free Cash Flow | -21.05 | -29.85 | -29.83 | -29.07 | -31.80 | -52.18 | -63.48 | -77.24 | -93.98 | -114.35 |
| WACC | ||||||||||
| PV LFCF | -48.03 | -53.80 | -60.26 | -67.49 | -75.59 | |||||
| SUM PV LFCF | -305.17 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 8.63 |
| Free cash flow (t + 1) | -116.63 |
| Terminal Value | -1,759.19 |
| Present Value of Terminal Value | -1,162.96 |
Intrinsic Value
| Enterprise Value | -1,468.12 |
|---|---|
| Net Debt | -8.08 |
| Equity Value | -1,460.04 |
| Shares Outstanding | 20.95 |
| Equity Value Per Share | -69.70 |